Product Description
| Cat Number | IM-020 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Scrambled version of CXCL8 (54-72) for use as a control |
| Modification | N terminal acetylation, C terminal amidation |
| Purity | >95% by HPLC |
| Biomarker Target | Protein-protein interactions,Chemokine receptors |
| Sequence Three Letter Code | Ac-Lys-Val-Arg-Glu-Lys-Asn-Glu-Lys-Trp-Phe-Val-Glu-Gln-Arg-Val-Ala-Leu-Asn-Ser-NH2 |
| Molecular Formula | C107H173N33O30 |
| Sl Sequence | Ac-KVREKNEKWFVEQRVALNS-NH2 |
| Solubility | Soluble in physiological buffers including PBS (>1mg./mL). Soluble in DMSO as a stock |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
MartÃnez€Burgo et al (2019), A C€terminal CXCL 8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation. Immunol. 157 173 PMID: 31013364 Related areas_x000D_ All peptides >All chemokine receptor modulators >All adhesion molecule research categories >All immunology research categories > |
| Note | The product is for research use only |
Share Item: